◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Sama Resources Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 136,909 141,634 212,589 160,579 221,554 --
General And Administrative Expense 136,909 141,634 212,589 160,579 221,554 --
Depreciation And Amortization In Income Statement 1,926 1,927 2,106 2,484 2,482 --
Other Operating Expenses -- -- -- 0.00 -- 27,365
Operating Expense 138,835 143,561 214,695 163,063 224,036 --
Operating Income -138,835 -143,561 -214,695 -163,063 -224,036 --
EBIT -138,835 -143,561 -214,695 -163,063 -224,036 --
Interest Income 2,637 8,039 13,870 19,561 22,206 --
Interest Income Non Operating 2,637 8,039 13,870 19,561 22,206 --
Net Interest Income 2,637 8,039 13,870 19,561 22,206 --
Other Income Expense -11.7M -558,290 -1.5M 5.1M 2.3M --
Other Non Operating Income Expenses 5,174 5,175 5,175 5,175 5,174 --
Special Income Charges -12.0M -2,070 0.00 6.4M -12,196 --
Write Off 12.0M -- -- -- 0.00 --
Gain On Sale Of Security 531,091 -379,509 -1.4M -1.2M 2.4M --
Earnings From Equity Interest -233,186 -181,886 -165,866 -106,030 -75,142 --
Pretax Income -11.8M -693,812 -1.7M 4.9M 2.1M --
Tax Effect Of Unusual Items 0.00 0.00 0.00 777,452 362,492 --
Net Income From Continuing And Discontinued Operation -11.8M -693,812 -1.7M 4.9M 2.1M --
Net Income From Continuing Operation Net Minority Interest -11.8M -693,812 -1.7M 4.9M 2.1M --
Net Income Including Noncontrolling Interests -11.8M -693,812 -1.7M 4.9M 2.1M --
Minority Interests 0.00 0.00 0.00 0.00 0.00 --
Net Income Common Stockholders -11.8M -693,812 -1.7M 4.9M 2.1M --
Net Income -11.8M -693,812 -1.7M 4.9M 2.1M --
EBITDA -136,909 -141,634 -212,589 -160,579 -221,554 --
Normalized EBITDA 11.3M 239,945 1.2M -5.3M -2.6M --
Reconciled Depreciation 1,926 1,927 2,106 2,484 2,482 --
Basic EPS -0.05 -0.00 -0.01 -- 0.01 0.00
Diluted EPS -0.05 -0.00 -0.01 -- 0.01 0.00
Basic Average Shares 220.1M 220.1M 220.1M -- 220.1M 220.1M
Diluted Average Shares 220.1M 220.1M 220.1M -- 220.6M 220.5M
Total Unusual Items -11.5M -381,579 -1.4M 5.2M 2.4M --
Total Unusual Items Excluding Goodwill -11.5M -381,579 -1.4M 5.2M 2.4M --
Tax Rate For Calcs 0.00 0.00 0.00 0.15 0.15 --
Normalized Income -364,210 -312,233 -361,516 533,094 90,694 --
Depreciation Amortization Depletion Income Statement 1,926 1,927 2,106 2,484 2,482 --
Depreciation Income Statement 1,926 1,927 2,106 2,484 2,482 --
Diluted NI Availto Com Stockholders -11.8M -693,812 -1.7M 4.9M 2.1M --
Gain On Sale Of Business 0.00 0.00 0.00 6.4M 0.00 --
Gain On Sale Of Ppe 0.00 -2,070 -- -3,514 -12,196 0.00
Net Income Continuous Operations -11.8M -693,812 -1.7M 4.9M 2.1M --
Net Income Discontinuous Operations -- -- -- 0.00 0.00 0.00
Net Non Operating Interest Income Expense 2,637 8,039 13,870 19,561 22,206 --
Other Gand A 134,160 137,431 205,855 131,423 190,050 --
Salaries And Wages 2,749 4,203 6,734 29,156 31,504 --
Selling And Marketing Expense -- -- -- 0.00 0.00 0.00
Total Expenses 138,835 143,561 214,695 163,063 224,036 --
Total Operating Income As Reported -138,835 -143,561 -214,695 -163,063 -224,036 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 938,752 956,081 1.4M 638,359 1.8M --
Cash Cash Equivalents And Short Term Investments 938,752 956,081 1.4M 638,359 1.8M --
Cash Financial -- -- -- 638,359 -- --
Accounts Receivable 0.00 19,881 596.00 76,870 30,563 --
Receivables 20,437 48,373 55,187 127,184 103,755 --
Prepaid Assets 10,020 41,867 52,646 15,718 22,600 --
Current Assets 969,209 1.0M 1.5M 1.8M 1.9M --
Gross PPE -- -- -- 107,467 -- --
Accumulated Depreciation -- -- -- -82,263 -- --
Net PPE 17,175 19,101 23,098 25,204 31,202 --
Investments And Advances 11.8M 23.5M 23.9M 25.2M 20.1M --
Long Term Equity Investment 3.9M 16.2M 16.1M 16.1M 9.8M --
Total Non Current Assets 11.9M 23.6M 23.9M 25.2M 20.1M --
Total Assets 12.8M 24.6M 25.4M 27.0M 22.1M --
Payables And Accrued Expenses 63,285 13,826 69,743 17,684 2,765 --
Current Liabilities 63,285 13,826 69,743 17,684 2,765 --
Total Non Current Liabilities Net Minority Interest 0.00 0.00 0.00 0.00 0.00 --
Total Liabilities Net Minority Interest 63,285 13,826 69,743 17,684 2,765 --
Common Stock 49.9M 49.9M 49.9M 49.9M 49.9M --
Capital Stock 49.9M 49.9M 49.9M 49.9M 49.9M --
Additional Paid In Capital 6.8M 6.8M 6.8M 6.8M 6.8M --
Retained Earnings -43.9M -32.1M -31.4M -29.7M -34.6M --
Common Stock Equity 12.8M 24.6M 25.3M 27.0M 22.1M --
Stockholders Equity 12.8M 24.6M 25.3M 27.0M 22.1M --
Total Equity Gross Minority Interest 12.8M 24.6M 25.3M 27.0M 22.1M --
Minority Interest -- 0.00 -- 0.00 0.00 0.00
Total Capitalization 12.8M 24.6M 25.3M 27.0M 22.1M --
Net Tangible Assets 12.8M 24.6M 25.3M 27.0M 22.1M --
Tangible Book Value 12.8M 24.6M 25.3M 27.0M 22.1M --
Working Capital 905,924 1.0M 1.4M 1.8M 1.9M --
Invested Capital 12.8M 24.6M 25.3M 27.0M 22.1M --
Share Issued 220.1M 220.1M 220.1M 220.1M 220.1M --
Ordinary Shares Number 220.1M 220.1M 220.1M 220.1M 220.1M --
Available For Sale Securities 7.9M 7.4M 7.7M 9.1M 10.3M --
Buildings And Improvements -- -- -- 0.00 -- --
Investmentin Financial Assets 7.9M 7.4M 7.7M 9.1M 10.3M --
Investmentsin Associatesat Cost 3.9M 16.2M 16.1M 16.1M 9.8M --
Non Current Accounts Receivable -- -- -- -- -- 9,695
Other Properties -- -- -- 18,200 -- --
Other Receivables -- 9,694 19,238 28,638 37,881 37,284
Properties -- -- -- 89,267 -- --
Restricted Cash -- -- -- 1.0M -- --
Taxes Receivable 20,437 18,798 35,353 21,676 35,311 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -27,076 -172,286 -109,484 -136,287 -178,299 --
Cash Flow From Continuing Operating Activities -27,076 -172,286 -109,484 -136,287 -178,299 --
Depreciation And Amortization 1,926 1,927 2,106 2,484 2,482 --
Depreciation Amortization Depletion 1,926 1,927 2,106 2,484 2,482 --
Stock Based Compensation 2,749 4,203 6,734 9,975 16,973 --
Change In Working Capital 99,548 -47,868 77,728 -10,871 -396.00 --
Changes In Account Receivables 19,881 -19,285 76,274 -46,307 420.00 --
Change In Receivables 18,242 -2,730 62,597 -32,672 -7,911 --
Change In Payables And Accrued Expense 49,459 -55,917 52,059 14,919 -13,951 --
Other Non Cash Items -53.00 -201.00 -347.00 -503.00 -648.00 --
Purchase Of PPE 0.00 0.00 0.00 0.00 0.00 --
Net PPE Purchase And Sale 0.00 0.00 0.00 0.00 6,859 --
Purchase Of Business 0.00 -240,000 -200,000 0.00 0.00 --
Investing Cash Flow 0.00 -240,000 -200,000 0.00 6,859 --
Cash Flow From Continuing Investing Activities 0.00 -240,000 -200,000 0.00 6,859 --
Net Issuance Payments Of Debt 9,747 9,745 9,747 9,746 9,746 --
Financing Cash Flow 9,747 9,745 9,747 9,746 9,746 --
Cash Flow From Continuing Financing Activities 9,747 9,745 9,747 9,746 9,746 --
Changes In Cash -17,329 -402,541 -299,737 -126,541 -161,694 --
Beginning Cash Position 956,081 1.4M 1.7M 1.8M 1.9M --
End Cash Position 938,752 956,081 1.4M 1.7M 1.8M --
Free Cash Flow -27,076 -172,286 -109,484 -136,287 -178,299 --
Asset Impairment Charge 12.0M -- -- -- 0.00 --
Change In Prepaid Assets 31,847 10,779 -36,928 6,882 21,466 --
Depreciation 1,926 1,927 2,106 2,484 2,482 --
Earnings Losses From Equity Investments 233,186 181,886 165,866 106,030 75,142 --
Gain Loss On Sale Of Business 0.00 0.00 0.00 -6.4M 0.00 --
Gain Loss On Sale Of PPE 0.00 2,070 -- 3,514 12,196 0.00
Net Business Purchase And Sale 0.00 -240,000 -200,000 0.00 0.00 --
Net Income From Continuing Operations -11.8M -693,812 -1.7M 4.9M 2.1M --
Net Long Term Debt Issuance 9,747 9,745 9,747 9,746 9,746 --
Net Other Financing Charges -- -- -- 0.00 -- --
Operating Gains Losses 233,186 183,956 165,866 -6.3M 87,338 --
Other Cash Adjustment Outside Changein Cash -- -- -- -- 0.00 0.00
Proceeds From Stock Option Exercised -- -- -- 0.00 0.00 --
Sale Of PPE 0.00 -- -- 0.00 6,859 --
Unrealized Gain Loss On Investment Securities -531,313 379,509 1.4M 1.2M -2.4M --
NEWS
Loading news...
TRENDING
Loading...